Medications

US health watchdog rejects Sanofi's MS drug

French drug giant Sanofi announced Monday US health authorities had rejected its Lemtrada drug for some forms of multiple sclerosis, which is already approved in the European Union, Canada and Australia.

Dec 30, 2013
popularity 5 / 5 (1) | comments 0

Tretten approved for genetic clotting disorder

(HealthDay)—Tretten (coagulation factor XIII A-Subunit recombinant) has been approved by the U.S. Food and Drug Administration to treat a very rare blood clotting disorder called congenital Factor XIII A-Subunit deficiency.

Dec 23, 2013
popularity not rated yet | comments 0

Stent to treat pancreatic cysts approved

(HealthDay)—The Axios Stent and Delivery System has been approved by the U.S. Food and Drug Administration to treat infected pancreatic cysts that won't drain on their own and could become life threatening, the FDA said ...

Dec 19, 2013
popularity not rated yet | comments 0

Vemurafenib: Result unchanged despite new data

Pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) reassessed vemurafenib (trade name: Zelboraf), a drug for the treatment ...

Dec 18, 2013
popularity not rated yet | comments 0

GSK to scrap individual sales targets (Update)

British drug company GlaxoSmithKline said Tuesday it would stop paying doctors to promote its products at speaking engagements and scrap individual sales targets, months after its ethics were challenged by a bribery scandal ...

Dec 17, 2013
popularity not rated yet | comments 0

New concerns over safety of common anesthetic

Patients receiving the widely used anesthesia drug etomidate for surgery may be at increased risk or mortality and cardiovascular events, according to a study in the December issue of Anesthesia & Analgesia, official journa ...

Dec 13, 2013
popularity 4 / 5 (1) | comments 0